Skip to menu Skip to content Skip to footer

2003

Journal Article

TIPS for gastric varices - Authors' reply

Tripathi, D, Therapondos, G, Hayes, PC and Redhead, DN (2003). TIPS for gastric varices - Authors' reply. Gut, 52 (5), 772-772.

TIPS for gastric varices - Authors' reply

2003

Conference Publication

The glycosylation pattern of alpha-1-acid glycoprotein (AGP) could indicate progression from hepatitis to cirrhosis

Anderson, NE, Hayes, P, Therapondos, G, Boyter, AC and Smith, KD (2003). The glycosylation pattern of alpha-1-acid glycoprotein (AGP) could indicate progression from hepatitis to cirrhosis. Annual Meeting of the British-Society-of-Gastroenterology, Birmingham England, Mar 23-26, 2003. LONDON: BMJ PUBLISHING GROUP.

The glycosylation pattern of alpha-1-acid glycoprotein (AGP) could indicate progression from hepatitis to cirrhosis

2003

Conference Publication

Single centre experience of transjugular intrahepatic portosystemic shunt (TIPSS) insertion for refractory ascites in cirrhosis

Ferguson, JW, Chillingworth, S, Tripathi, D, Therapondos, G, Redhead, D and Hayes, PC (2003). Single centre experience of transjugular intrahepatic portosystemic shunt (TIPSS) insertion for refractory ascites in cirrhosis. Annual meeting of the British-Society-of-Gastroenterology, Birmingham England, Mar 23-26, 2003. LONDON: BRITISH MED JOURNAL PUBL GROUP.

Single centre experience of transjugular intrahepatic portosystemic shunt (TIPSS) insertion for refractory ascites in cirrhosis

2002

Journal Article

Is this the end for protocol early posttransplant liver biopsies?

Therapondos, G. and Hayes, P. C. (2002). Is this the end for protocol early posttransplant liver biopsies?. Liver Transplantation, 8 (12), 1154-1155. doi: 10.1053/jlts.2002.36731

Is this the end for protocol early posttransplant liver biopsies?

2002

Conference Publication

The glycosylation pattern of alpha-1-acid glycoprotein (AGP) could indicate progression from hepatitis to cirrhosis

Anderson, NE, Hayes, PC, Therapondos, G, Boyter, AC and Smith, KD (2002). The glycosylation pattern of alpha-1-acid glycoprotein (AGP) could indicate progression from hepatitis to cirrhosis. 7th Annual Conference of the Society-for-Glycobiology, Boston Massachusetts, Nov 09-12, 2002. CARY: OXFORD UNIV PRESS INC.

The glycosylation pattern of alpha-1-acid glycoprotein (AGP) could indicate progression from hepatitis to cirrhosis

2002

Conference Publication

The glycosylation pattern of alpha-1-acid glycoprotein (AGP) as a potential diagnostic marker in liver disease

Anderson, N, Hayes, P, Therapondos, G, Boyter, A and Smith, K (2002). The glycosylation pattern of alpha-1-acid glycoprotein (AGP) as a potential diagnostic marker in liver disease. 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), Boston Massachusetts, Nov 01-05, 2002. PHILADELPHIA: W B SAUNDERS CO.

The glycosylation pattern of alpha-1-acid glycoprotein (AGP) as a potential diagnostic marker in liver disease

2002

Journal Article

A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases

Anderson, N, Pollacchi, A, Hayes, P, Therapondos, G, Newsome, P, Boyter, A and Smith, K (2002). A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases. Biomedical Chromatography, 16 (6), 365-372. doi: 10.1002/bmc.167

A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases

2002

Journal Article

Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation

Tripathi, D., Therapondos, G., Redhead, D.N., Madhavan, K.K. and Hayes, P.C. (2002). Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. European Journal of Gastroenterology & Hepatology, 14 (8), 827-832. doi: 10.1097/00042737-200208000-00003

Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation

2002

Conference Publication

Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus

Therapondos, G., Flapan, A.D., Dollinger, M.M., Garden, O.J., Plevris, J.N. and Hayes, P.C. (2002). Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Annual AASLD Meeting, Dallas, TX United States, 1999. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1053/jlts.2002.34381

Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus

2002

Journal Article

The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations

Tripathi, D, Therapondos, G, Jackson, E, Redhead, DN and Hayes, PC (2002). The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut, 51 (2), 270-274. doi: 10.1136/gut.51.2.270

The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations

2002

Journal Article

Management of gastro-oesophageal varices

Therapondos, G and Hayes, PC (2002). Management of gastro-oesophageal varices. Clinical Medicine, 2 (4), 297-302. doi: 10.7861/clinmedicine.2-4-297

Management of gastro-oesophageal varices

2002

Journal Article

Endoscopic use of human thrombin in bleeding gastric varices

Yang, WL, Tripathi, D, Therapondos, G, Todd, A and Hayes, PC (2002). Endoscopic use of human thrombin in bleeding gastric varices. American Journal of Gastroenterology, 97 (6) PII S0002-9270(02)04132-1, 1381-1385. doi: 10.1016/S0002-9270(02)04132-1

Endoscopic use of human thrombin in bleeding gastric varices

2002

Conference Publication

The role of the transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of bleeding gastric varices: Clinical and haemodynamic correlations

Tripathi, D, Therapondos, G, Jackson, E, Redhead, DN and Hayes, PC (2002). The role of the transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of bleeding gastric varices: Clinical and haemodynamic correlations. AMSTERDAM: ELSEVIER SCIENCE BV.

The role of the transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of bleeding gastric varices: Clinical and haemodynamic correlations

2002

Journal Article

Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating β-blocker, in patients with cirrhosis and portal hypertension

Tripathi, D, Therapondos, G, Lui, HF, Stanley, AJ and Hayes, PC (2002). Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating β-blocker, in patients with cirrhosis and portal hypertension. Alimentary Pharmacology & Therapeutics, 16 (3), 373-380. doi: 10.1046/j.1365-2036.2002.01190.x

Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating β-blocker, in patients with cirrhosis and portal hypertension

2001

Conference Publication

Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodilating beta-blocker in patients with cirrhosis and portal hypertension

Tripathi, D, Therapondos, G, Lui, HF, Stanley, AJ and Hayes, PC (2001). Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodilating beta-blocker in patients with cirrhosis and portal hypertension. LONDON: BRITISH MED JOURNAL PUBL GROUP.

Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodilating beta-blocker in patients with cirrhosis and portal hypertension

2001

Conference Publication

Thrombin in gastric varices

Yang, WL, Tripathi, D, Therapondos, G and Hayes, PC (2001). Thrombin in gastric varices. LONDON: BRITISH MED JOURNAL PUBL GROUP.

Thrombin in gastric varices

2000

Conference Publication

Is TIPSS a valuable therapeutic option for the treatment of chronic anemia secondary to portal hypertensive gastropathy?

Iacuzzi, LD, Therapondos, G and Hayes, PC (2000). Is TIPSS a valuable therapeutic option for the treatment of chronic anemia secondary to portal hypertensive gastropathy?. PHILADELPHIA: W B SAUNDERS CO.

Is TIPSS a valuable therapeutic option for the treatment of chronic anemia secondary to portal hypertensive gastropathy?

2000

Conference Publication

Alpha-1-acid glycoprotein as a marker for the onset and/or intensity of liver diseases

Anderson, N, Smith, K, Hayes, P, Therapondos, G, Newsome, P and Boyter, A (2000). Alpha-1-acid glycoprotein as a marker for the onset and/or intensity of liver diseases. CARY: OXFORD UNIV PRESS INC.

Alpha-1-acid glycoprotein as a marker for the onset and/or intensity of liver diseases

2000

Conference Publication

Transjugular intrahepatic portosystemic stent shunt(TIPSS) and its effects on orthotopic liver transplantation(OLT)

Tripathi, D, Therapondos, G, Madhaven, KK and Hayes, PC (2000). Transjugular intrahepatic portosystemic stent shunt(TIPSS) and its effects on orthotopic liver transplantation(OLT). PHILADELPHIA: W B SAUNDERS CO.

Transjugular intrahepatic portosystemic stent shunt(TIPSS) and its effects on orthotopic liver transplantation(OLT)

2000

Conference Publication

Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodialting beta-blocker in patients with cirrhosis and portal hypertension

Tripathi, D, Therapondos, G, Lui, HF, Stanley, AJ and Hayes, PC (2000). Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodialting beta-blocker in patients with cirrhosis and portal hypertension. PHILADELPHIA: W B SAUNDERS CO.

Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodialting beta-blocker in patients with cirrhosis and portal hypertension